These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11890118)
1. Recent development of anti-cancer drugs for treatment of GI malignancies in Japan. Taguchi T Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():76-80. PubMed ID: 11890118 [No Abstract] [Full Text] [Related]
2. Treatment of advanced disease and new drugs. Frustaci S; Buonadonna A; La Mura N; Berretta M; De Paoli A Suppl Tumori; 2003; 2(5):S48-50. PubMed ID: 12914391 [No Abstract] [Full Text] [Related]
3. [Development of oral drugs in the standard therapy for metastatic colorectal cancer patients]. Kato K Nihon Rinsho; 2011 Apr; 69 Suppl 3():454-8. PubMed ID: 22214003 [No Abstract] [Full Text] [Related]
4. Colon cancer: new drug options improve on 5-FU. McCann J J Natl Cancer Inst; 1998 Jul; 90(13):963-5. PubMed ID: 9665142 [No Abstract] [Full Text] [Related]
9. [Diagnosis of and therapy for pancreatic neoplasms]. Motoo Y Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):818-21. PubMed ID: 17506324 [No Abstract] [Full Text] [Related]
10. Radiotherapy for localized rectal cancer. Deutsch E; Ezra P; Mangoni M; Ducreux M Ann Oncol; 2007 Jul; 18 Suppl 9():ix105-13. PubMed ID: 17631562 [No Abstract] [Full Text] [Related]
11. Oral treatment for gastric cancer: new choices, better choices? Cascinu S Lancet Oncol; 2008 Mar; 9(3):188-9. PubMed ID: 18308239 [No Abstract] [Full Text] [Related]
12. S-1 for the treatment of gastrointestinal cancer. Satoh T; Sakata Y Expert Opin Pharmacother; 2012 Sep; 13(13):1943-59. PubMed ID: 22860709 [TBL] [Abstract][Full Text] [Related]
13. [Predicting drug efficacy-fluorinated pyrimidines (fluorouracil, S-1 and capecitabine)]. Hirashima Y; Shirao K Gan To Kagaku Ryoho; 2012 Nov; 39(11):1603-7. PubMed ID: 23152010 [TBL] [Abstract][Full Text] [Related]
14. [Systemic treatment of colorectal cancers--factual standards and perspectives]. Miron L Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):752-8. PubMed ID: 14756014 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy, which drugs and when. Koopman M; Punt CJ Eur J Cancer; 2009 Sep; 45 Suppl 1():50-6. PubMed ID: 19775604 [No Abstract] [Full Text] [Related]
16. An update on biochemotherapy of advanced gastric and gastroesophageal adenocarcinoma. Haghighat P; Bekaii-Saab T J Natl Compr Canc Netw; 2008 Oct; 6(9):895-900. PubMed ID: 18926099 [TBL] [Abstract][Full Text] [Related]
17. [Present status of chemotherapy for colorectal cancer in countries outside of Japan]. Doi T; Ohtsu A Nihon Rinsho; 2003 Sep; 61 Suppl 7():368-73. PubMed ID: 14574915 [No Abstract] [Full Text] [Related]
18. Practical considerations in the use of oral fluoropyrimidines. Hoff PM Semin Oncol; 2003 Jun; 30(3 Suppl 6):88-92. PubMed ID: 12802799 [TBL] [Abstract][Full Text] [Related]
19. Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents? Pozzo C; Barone C Oncologist; 2008 Jul; 13(7):794-806. PubMed ID: 18614586 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin. Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]